Role of biotechnology and life sciences in the bid
The extensive scientific and academic platform offered by the university, the university hospital and all of the city’s research facilities were presented as a source of innovation in the bid in the area of biotechnology and life sciences. The amount of research funding acquired for Mainz-based projects and the innovative concepts emerging from the city were both addressed.
TRON gGmbH and its innovative approach to translating fundamental scientific research into clinical applications served as a prime example of how Mainz can accelerate innovation. Arguably the most famous example cited in the bid was the contribution to the development of Comirnaty®, the world’s first Covid-19 vaccine developed by BioNTech SE.
The bid also demonstrated how networks such as the Ci3 and curATime cluster, the information and education platform CIMT, FORTHEM and the Mainz Research Alliance facilitate collaboration and the sharing of knowledge among stakeholders both in the local area and on the international stage.
Great delight in award and impressive innovations
Mayor Günter Beck, who accepted the award in Brussels, was overjoyed to receive the accolade. He stressed that it was a special prize that everyone can take great pride in, and was a just reward for the dedication and teamwork of many different stakeholders in Mainz who continue to come up with impressive innovations.
More information is available here:
City of Mainz website